SCHEMBL3441255

SCHEMBL3441255

CCOC(=O)[C@H](C)C(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
TRPA1 O75762 1/20 0.37
PIN1 Q13526 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
NPC1 O15118 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
CAD P27708 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4361328 1.00 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL141446 0.84 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL8800602 0.81 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL28186389 0.81 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15
Ammonia Solution, Strong SCHEMBL28791130 0.81 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15
Ethane SCHEMBL9181718 0.81 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL5143571 0.79 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL2169170 0.77 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL4112176 0.77 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL41804 0.77 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200615-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS Gilead Palo Alto, Inc. (US) 2010-06-30 EP disclosed
WO-2009052310-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC (US) 2009-04-23 WO disclosed